Stroke

About the Disease
Cerebrovascular Disease, also known as cerebrovascular disorder, is related to basal ganglia cerebrovascular disease and stroke, ischemic, and has symptoms including headache, transient ischemic attacks, stereotypic symptoms and angina pectoris. An important gene associated with Cerebrovascular Disease is HOTAIR (HOX Transcript Antisense RNA), and among its related pathways/superpathways are Signal Transduction and Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs). The drugs Acetylcarnitine and Benzocaine have been mentioned in the context of this disorder. Affiliated tissues include brain, bone marrow and heart, and related phenotypes are homeostasis/metabolism and growth/size/body region

Common Targets
CXADR | F12 | KCNQ2 | GCGR | Monoamine oxidase (MAO) (nonspecified subtype) | CASZ1 | CA4 | CDK7 | LOC105375175 | SH3PXD2A | CDK1 | TCF7L2 | GRIN2B | FLT3 | GSK3A | ACTB | CUBN | ADRA2C | ALOX15 | RPS6KA4 | IL4 | MTHFR | NADPH Oxidase (nonspecified subtype) | Fibrinogen | Superoxide dismutase (SOD) (nonspecified subtype) | CYP19A1 | GSTP1 | HMOX1 | Fibroblast Growth Factor Receptor (FGFR) (nonspecified subtype) | Histone deacetylase (nonspecified subtype) | TBXAS1 | GPR55 | SLC29A2 | BDKRB2 | SLC5A2 | NT5C2 | CHEK2 | SCN2A | SIRT2 | FUT6 | Serine/threonine-protein kinase (PAK) (nonspecified subtype) | GJB2 | HTR7 | MAS1L | ADK | Prostaglandin EP Receptor (nonspecified subtype) | ITGAM | Glutamate Receptor Ionotropic AMPA Receptor | LINC01394 | CETP | PHACTR1 | CASP7 | LPL | MLKL | F9 | P2RY1 | Proteasome Complex | RGS7 | Mitogen-activated protein kinase p38 (MAPK p38) (nonspecified subtype) | ENPP2 | AK8 | PIK3CG | SLC9A1 | DUSP3 | Na+/H+ Exchanger (NHE) (nonspecified subtype) | Corticotropin-Releasing Factor (CRF) Receptor (nonspecified subtype) | JAK3 | MMUT | G5243 | G6647 | EDNRA | VWF | CACNA1B | P2RX1 | TAFA5 | G5599 | MPO | NTRK2 | SLC28A3 | 5-Hydroxytryptamine Receptor 3 (5-HT3 receptor) (nonspecified subtype) | PDE4D | G6714 | TLR7 | KCNAB2 | IL10 | CSF3 | m-Calpain | Cyclin B (nonspecified subtype) | ILF3 | JAK1 | GHRL | GAPDH | PMF1 | CISD2 | Kainate Receptor (GluR) (nonspecified subtype) | Integrin alpha4beta1 (VLA-4) receptor | AURKA | DTL | CDH13 | G3309 | Protein Phosphatase 2A | SCN10A | HPS4 | Calpain (nonspecified subtype) | IFNB1 | G114548 | Integrin alphaMbeta2 (MAC-1) Receptor | LDLR | ABCD4 | RORC | SLC12A3 | NOTCH3 | AVPR1A | Metabotropic glutamate (mGluR) receptor (nonspecified subtype) | C1S | FKBP4 | CRBN | PDK1 | Voltage-gated K(v) channel (nonspecified subtype) | GRIN2C | PREP | BDNF | GRIK1 | PTGES | P2Y purinoceptor (nonspecified subtype) | RYR1 | KDR | gamma-Secretase | G1956 | DGAT1 | SRR | KCNA3 | GRM5 | TLR8 | GRIN1 | L-type voltage-dependent calcium channel complex | Cyclophilins (nonspecified subtype) | EPHB3 | Serine/Threonine Kinase (nonspecified subtype) | SYNE2 | Glycogen phosphorylase (nonspecified subtype) | AQP4 | PTGER3 | CCNH | G7124 | NPY1R | CDK2 | KCNK18 | Kir 3.1/3.4 | Tyrosine-Protein Kinases Src (nonspecified subtype) | NOS1 | ACP1 | JAK2 | Cyclin-dependent kinase (nonspecified subtype) | AHCY | NDUFB6 | GNB3 | LRRK2 | ALOX5AP | Phosphodiesterase 1 (PDE1) (nonspecified subtype) | Interleukin-1 (nonspecified subtype) | CSK | NR3C2 | IKBKB | CDK5/p25 | NR1H2 | OPRK1 | STRIP1 | ADRA2B | FLG | RPS6KA3 | CYP2C19 | KCND3 | VKORC1 | PDK2 | IPO11 | PDE4B | AVPR1B | MGLL | beta-Secretase (nonspecified subtype) | HDAC6 | HMOX2 | Acid-Sensing Ion Channel (ASIC) (nonspecified subtype) | AMP-activated protein kinase (AMPK) | LPAR1 | ADIPOQ | LOC105377732 | Phospholipase A2 (nonspecified subtype) | EGR1 | G3620 | Integrin alphavbeta3 (vitronectin) receptor | RTN4 | CTNNA2 | KCNQ3 | KYNU | ICAM4 | EPHX2 | ALOX12 | G1/S-specific cyclin-E (nonspecified subtype) | CD320 | HDAC5 | T-Type Calcium Channel | GABRB2 | MAPK11 | COL4A1 | SCD | SDC2 | Phosphodiesterase IV (PDE4) (nonspecified subtype) | CYP17A1 | G6774 | BTK | CALM1 | HIF1A | APLNR | C5 | NPM1 | HDAC7 | ROCK1 | OPRM1 | SDC4 | Heat shock protein 90 (nonspecified subtype) | SCARB1 | Casein kinase I (nonspecified subtype) | G protein-Coupled Inwardly-Rectifying Potassium Channel (GIRK) (nonspecified subtype) | CLYBL | VIP | GABRG2 | CIRBP | IGFBP1 | Alpha-2 Adrenergic receptors (nonspecified subtype) | CTSL | MMP3 | SIGMAR1 | AURKB | NR1H3 | CHRM1 | ACE | DSG3 | CDK6 | GRIK2 | ATP5IF1 | G3479 | CARD9 | KCNJ1 | Ribonucleoside-diphosphate reductase | GRIN2D | AMP Deaminase (nonspecified subtype) | MAP3K11 | RAMP2 | Protein Kinase B (PKB/Akt) (nonspecified subtype) | IL1B | PTPRG | Phospholipase C (nonspecified subtype) | GRIA2 | KCNK2 | ALDH2 | NOX4 | G842 | LCK | FKBP1A | Alcohol Dehydrogenase (nonspecified subtype) | PPARA | CNR2 | Calcium channel (nonspecified subtype) | F3 | CDKN2B | GRM2 | FPR1 | G5728 | Lipoxygenase (nonspecified subtype) | G1432 | CSF3R | MMP12 | P2RX3 | S1PR4 | alpha-Secretase (nonspecified subtype) | Matrix Metalloproteinase (MMP) (nonspecified subtype) | NFATC2 | PDE10A | TYR | SGK2 | CDK5 | Glutamate Transporter (nonspecified subtype) | Calcium-Activated K(Ca) Potassium Channel (nonspecified subtype) | Phosphatidylinositol 3-kinase (PI3K) (nonspecified subtype) | SMPD1 | CHRNA9 | G3569 | SLC9A3 | KCNN4 | POU5F1 | HTRA1 | Nicotinic alpha3beta4 Receptor | KEAP1 | SLC6A9 | NPY2R | PRPF8 | PANX1 | Protein Tyrosine Phosphatase (PTP) (nonspecified subtype) | IAPP | Protein kinase C (nonspecified subtype) | ESR2 | ADORA2B | TYK2 | NTSR2 | PIK3CB | MTRNR2L8 | ANXA4 | APOC3 | CDK9/Cyclin T1 | alpha-Adrenoceptor (nonspecified subtype) | Opioid receptor (nonspecified subtype) | Oxysterols receptor LXR (nonspecified subtype) | F10 | DDR2 | Chloride channel (nonspecified subtype) | PCSK9 | AVPR2 | RNF213 | Neurotrophic Factor (nonspecified subtype) | ADORA1 | Acetylcholine Receptors (Nicotinic) (nAChR) (nonspecified subtype) | Adenylate Cyclase (nonspecified subtype) | ZFHX3 | TRPM8 | PRKAG2 | Guanylate cyclase (nonspecified subtype) | HTR1A | HTR2B | LOC105375977 | PGAM5-KEAP1-NRF2 Complex | Amylin receptor | VCAM1 | HMGCR | G4780 | KIT | MAP2K1 | MAOA | VIPR1 | G23411 | UTS2R | Nicotinic alpha4beta2 receptor | SCN4A | TCN1 | NPPA | DRD2 | NF-kappaB (NFkB) | CA7 | NPPA-AS1 | Sphingomyelin phosphodiesterase (nonspecified subtype) | KCNE1 | SMPD2 | NR1I2 | Integrin alpha5beta1 (VLA-5) receptor | KCNJ3 | CDKN2B-AS1 | GIPR | LOC100507053 | ARHGEF7 | CHRNA7 | EDNRB | CASP4 | DYRK3 | ITGA4 | Integrin alphaIIbbeta3 (fibrinogen gpIIb/IIIa) receptor | ITGB2 | ABCA1 | G4137 | C3AR1 | PGR | BORCS7-ASMT | ICAM1 | CELSR2 | SH3YL1 | S1PR3 | G7852 | C10orf88 | G5595 | BCHE | KCNC3 | KCNQ Channels (K(v) 7) (nonspecified subtype) | DYRK1A | ZAP70 | TRPV2 | Estrogen receptor (nonspecified subtype) | CASP2 | PRKCH | ADRA2A | cAMP-Dependent protein kinase (PKA) | MMAA | LOC101928272 | GABA(A) receptor | SLC6A11 | SOD2 | CDK9 | CNR1 | Orexin receptor (nonspecified subtype) | CES1 | DLG4 | MAPK9 | HSD11B1 | IGFBP3 | TREM2 | PPARD | RORA | Interleukin-12 (IL-12) | G1029 | PYCARD | Anandamide membrane transporter (AMT) | HERC2 | G581 | GRIK3 | GABRB3 | 15-Lipoxygenase (nonspecified subtype) | DPP4 | TRPC6 | PLAT | GRM8 | CPB2 | G142 | KCNA5 | MIR210 | TCN2 | FOLR3 | PRKCD | MFN2 | Amyloid beta A4 precursor protein-binding family (APP-BP) (nonspecified subtype) | Tyrosine Kinase (nonspecified subtype) | PLG | NRP1 | BOLL | AKT2 | CAV1 | GRIN2A | EYS | Cysteine Protease (nonspecified subtype) | LHCGR | MAG | CCNT1 | RYR2 | KCNK3 | HDAC1 | P2RY12 | AKR1B1 | Pyruvate dehydrogenase kinase (nonspecified subtype) | ADORA2A | RTEL1 | GUCY1A1 | QSOX1 | CYP2R1 | TGFBR1 | TSPO | F2 | BACE1 | CASP8 | G9734 | COL4A2 | ADRB1 | SMARCA4 | FOXF2 | Heme Oxygenase (HO) (nonspecified subtype) | Trypsin (nonspecified subtype) | Voltage-Gated Sodium Channel Complex | KCNJ5 | TRPV1 | WDR12 | CXCR3 | CHRM3 | sigma Receptor (nonspecified subtype) | ADORA3 | Triacylglycerol Lipase (TG Lipase) (nonspecified subtype) | OPRD1 | SERPINE1 | CBS | NADSYN1 | PDE4C | IPO11-LRRC70 | STK17A | Kallikrein (nonspecified subtype) | Prostanoid TP receptor (nonspecified subtype) | LIPC | EPHA4 | XDH | KCNE3 | CCR9 | P2X Receptor (nonspecified subtype) | BCAT1 | FOLH1 | LRRC4 | CAPN1 | GCLM | Peptidylprolyl Isomerase (nonspecified subtype) | LPAR4 | CALCRL | GSTT1 | CDK1/Cyclin B | beta-Adrenoceptor (nonspecified subtype) | GSK3B | LINC02210-CRHR1 | ADCYAP1R1 | TRPM2 | NTRK1 | TRPM7 | PTGS1 | Glycogen synthase kinase 3 (GSK-3) (nonspecified subtype) | CYP26A1 | STS | PTPN1 | MIR195 | ACHE | KCNE4 | NUAK Family SNF1-like Kinase (nonspcified subtype) | ABCC6 | PDE6D | PPARG | NR1H4 | PDE1B | Elastase (nonspecified subtype) | EDN1 | EPOR | HDAC4 | CYP26B1 | Solute carrier family 29 member (nonspecified subtype) | Actin (nonspecified subtype) | FLT4 | GRM3 | G3480 | SOX9 | SST | MMP13 | GGT1 | Vascular endothelial growth factor receptor (VEGFR) (nonspecified subtype) | FBXW7-AS1 | HSPA1A | Serine protease (nonspecified subtype) | ABCC8 | PTPRB | ADH5 | CRHR1 | Caspase (nonspecified subtype) | FAAH | KDM1A | CHI3L1 | G2099 | RORB | KCNE2 | PDE2A | CHRM5 | HTR6 | CLK1 | G3630 | TXNRD1 | FGFR1 | ENPP1 | GABRD | Sodium channel (nonspecified subtype) | SORD | GABRA5 | SERPINA1 | GRM1 | Heat shock protein 70 (nonspecified subtype) | L-Type calcium channel (nonspecified subtype) | KCNQ1 | GJA1 | CDK2/Cyclin A | CCNE1 | Cannabinoid receptor (nonspecified subtype) | CCKAR | LIMASI | High affinity cAMP-specific 3',5'-cyclic phosphodiesterase 7 (nonspecified protein) | F2RL3 | CORIN | Adenosine receptor (nonspecified subtype) | FLT1 | SIK2 | G836 | TMEM97 | Poly [ADP-ribose] polymerase (nonspecified subtype) | FASN | ITGB3 | BRSK1 | CYP4F2 | MAPK10 | Mitochondrial pyruvate carrier complex (MPC) | Mitogen-Activated Protein Kinase (nonspecified subtype) | KCNS3 | FPR2 | DYRK1B | FLNB | PON1 | Janus Kinase (nonspecified subtype) | HTR1B | SRSF2 | GC | ADAMTS2 | 5-Hydroxytryptamine Receptor 2 (5-HT2) (nonspecified subtype) | PLA2G7 | MAGI1 | EIF2AK3 | Chemokine receptor (nonspecified subtype) | EGLN1 | G4318 | PLAU | Aurora Kinase (nonspecified subtype) | alpha-6 beta-2 Nicotinic receptor | TH | CA2 | PDE4A | MASP1 | Hypoxia-Inducible Factor Prolyl Hydroxylase (nonspecified subtype) | Nicotinic alpha9alpha10 Receptor | MAS1 | G196 | NOS3 | CDK5RAP3 | KCNH1 | F11 | GABRA2 | Angiotensin receptor (AT) (nonspecified subtype) | PARK7 | Cyclooxygenase (COX) (nonspecified subtype) | ADRB2 | Large Conductance BK(Ca) Potassium Channel (Maxi K+ Channel) (nonspecified subtype) | Complement Complex | CDK2/Cyclin E | CDK7/Cyclin H | alpha1-Adrenoceptor (nonspecified subtype) | LIPE | G7157 | ROCK2 | Imidazoline I2 receptor (I2) | F2R | Endothelin receptor (nonspecified subtype) | SLC6A4 | CYP4A11 | LYN | FUT2 | SH2B3 | LINC01492 | MAP2K2 | CTSB | KLKB1 | GAA | PNLIP | ANK2 | AGTR2 | FABP4 | NOX3 | PDE5A | Calcium/calmodulin-dependent protein kinase type II (CaMK-II) | CALCR | IL2 | Cyclin-dependent kinase inhibitor (nonspecified subtype) | CASP1 | GRM4 | Gamma-glutamyl transferase (nonspecified subtype) | 5-Hydroxytryptamine Receptor (nonspecified subtype) | APP | LOC100505841 | GPR39 | WDFY4 | APOB | NMDA receptor | AGTR1 | ND5 | CASP6 | DYRK2 | PARP2 | alpha-Amylase (nonspecified subtype) | AGER | C3 | Cyclin A (nonspecified subtype) | NAMPT | Nitric oxide synthase (NOS) (nonspecified subtype) | GPR182 | MIA3 | NT5E | GABRA6 | Ryanodine receptor (nonspecified subtype) | Glutamate Receptor Ionotropic (nonspecified subtype) | TRDMT1 | MMP2 | TUB | LRCH1 | Collagenase (nonspecified subtype) | cGMP-inhibited 3',5'-cyclic phosphodiesterase 3 (PDE3) (nonspecified subtype) | GRK2 | Protein phosphatase-1 | NR3C1 | FAS | NMUR2 | MMP14 | G367 | SLC29A1 | G8878 | SLC2A4 | SERPING1 | KRR1 | Na+/Ca2+ Exchanger (NCX) (nonspecified subtype) | G4233 | PDE1A | GPR17 | CCL2 | CYP27B1 | ABCC4 | REN | CRP | LPAR3 | PRKCE | HTR2A | TAAR1 | Mitogen-activated protein kinase (JNK) (nonspecified subtype) | CX3CR1 | SLC8A1 | Dual Specificity Mitogen-Activated Protein Kinase Kinase (MEK) (nonspecified subtype) | CYP11B2 | LOC101928635 | CHRNB2 | NADPH Oxidase Complex | SLC1A2 | FYN | TRPA1 | LOC105377134 | Melanocortin receptor (nonspecified subtype) | VDR | LTA4H | LOC105372798 | GSTM1 | Glutathione peroxidase (nonspecified subtype) | ZDHHC6 | NOS2 | Potassium Channels (nonspecified subtype) | P2RX7 | RIPK1 | STING1 | Vasoactive intestinal polypeptide receptor (VIP-R) (nonspecified subtype) | Rho kinase (ROCK) (nonspecified subtype) | DRD3 | PDE7A | Epoxide Hydrolase (nonspecified subtype) | CHRM2 | Voltage-Gated Calcium Channel alpha-2/delta (nonspecified subtype) | KCNB1 | GOLGB1 | CMA1 | ALOX5 | UCP2 | LIPG | CCR5 | MASTL | GYPA | G5743 | RHOA | TRPM3 | PDGFRA | PI3 | MFN1 | RET | G2146 | VHL | FGF2 | AOC3 | mu-Calpain (calpain 1) | DHFR | MAOB | NGF | HAAO | ADAMTS12 | PTAFR | Soluble guanylyl cyclase | SLC6A3 | CAPN2 | GLP1R | PTGER2 | NLRP3 Inflammasome | KMO

Note: If you'd like to get a target analysis report for Stroke, or if you are interested to learn how our AI-powered BDE-Chem can design therapeutic molecules to interact with the target(s) above against the disease of Stroke at a cost 90% lower than traditional approaches, please feel free to contact us at BD@silexon.tech.

Other Diseases

Fibrosis | Amebiasis | Anthrax | Filariasis | Diabetes Type 2 | Neuroleptic Malignant Syndrome | Werner's Syndrome | Esophagitis, Eosinophilic | Long-chain 3-hydroxyacyl-coenzyme A Dehydrogenase Deficiency | Bronchiectasis | Familial Pheochromocytoma-paraganglioma | Chondromyxoid Fibroma | Ameloblastoma | Primary Lateral Sclerosis | Non-proliferative Diabetic Retinopathy | Charcot-Marie-Tooth Disease, Type 2 | Leigh Syndrome | Thyroid Hormone Resistance | Seminoma | Conjunctivitis | Hypoglycemia | Congenital Generalized Lipodystrophy | Sorsby Fundus Dystrophy | Pompe Disease | Polyneuropathy | Hemorrhoids | Waardenburg Syndrome | Crouzon Syndrome With Acanthosis Nigricans | Hypogammaglobulinemia | Waardenburg Syndrome Type 1 | Familial Hypertrophic Cardiomyopathy | Communication Disorders | Acromegaly | Wagner Disease | Pilomatrix Carcinoma | Megaloblastic Anemia | Abetalipoproteinemia | Pyruvate Decarboxylase Deficiency | Pure Red Cell Aplasia | Nance-Horan Syndrome | Angiodysplasia | Crimean-Congo Hemorrhagic Fever | Colorectal Adenoma | Blue Rubber Bleb Nevus Syndrome | Acute Kidney Injury | Specific Granule Deficiency | Acute Tubular Necrosis | Juvenile Polyposis | Guttate Psoriasis | Spinal Muscular Atrophy Type 3 | Ocular Surface Squamous Neoplasia | Monilethrix | Citrullinemia | Epidermal Nevus Syndrome | Diabetic Neuropathy | Binge Eating Disorder | Autonomic Neuropathy | Cholecystitis | Inflammatory Joint Disease | Becker Muscular Dystrophy | Bartsocas-Papas Syndrome | Retinoschisis | Schizophrenia | Leiomyoma | Kashin-Beck Disease | Graft-versus-host Disease | WAGR Syndrome | Hereditary Sensory Neuropathy Type 1 | Familial Thoracic Aortic Aneurysm | Keratitis-ichthyosis-deafness Syndrome | Tremor | Hyperglycemia | Congenital Torticollis | Aromatic L-amino Acid Decarboxylase Deficiency | Waardenburg Syndrome Type 2 | Carney Triad | Gastroenteritis, Eosinophilic | Batten Disease | Polycythemia Vera | Autoimmune Disease | Glaucomatocyclitic Crisis | Smoldering Myeloma | Danon Disease | Leukocyte Adhesion Deficiency | Multiple Sclerosis, Secondary Progressive | Endometriosis | Galactosemia | Coronary Restenosis | Hypobetalipoproteinemias | Spinocerebellar Ataxia | Porphyria, Acute Intermittent | Acute Chest Syndrome | Medium-chain Acyl-CoA Dehydrogenase Deficiency | Liver Failure | Rheumatoid Arthritis | Glucagonoma | Familial Hemiplegic Migraine | Corticobasal Syndrome | Thalassemia | Benign Recurrent Intrahepatic Cholestasis 1 | Malnutrition | Frontotemporal Dementia | Primary Ovarian Insufficiency | Rhinitis | Hyperandrogenemia | Aplastic Anemia | Hyperbilirubinemia | Emery-Dreifuss Muscular Dystrophy | Exotropia | Benign Familial Pemphigus | Oculocutaneous Albinism Type 2 | Achromatopsia | Hemolytic Anemia | Dent Disease | Chorioretinitis | Otopalatodigital Syndrome Type 2 | Sepiapterin Reductase Deficiency | 3-methylglutaconic Aciduria Type IV | Avellino Corneal Dystrophy | Cutaneous Angiosarcoma | Diffuse Intrinsic Pontine Glioma | Acrodysostosis | Cannabis Abuse | Parkinson Disease 6, Autosomal Recessive Early-onset | Retinitis Pigmentosa | Acrocallosal Syndrome | Amelogenesis Imperfecta | Kabuki Syndrome 2 | Cri-du-chat Syndrome | Frontometaphyseal Dysplasia | Hemophagocytic Lymphohistiocytosis | Mitochondrial Encephalomyopathy | Frontotemporal Dementia With Amyotrophic Lateral Sclerosis | Chorea-acanthocytosis | Myositis, Focal | Hennekam Lymphangiectasia-lymphedema Syndrome | Cancer, Kidney | Hypertrophic Osteoarthropathy, Primary, Autosomal Recessive 2 | Chronic Mucocutaneous Candidiasis | Congenital Absence Of Vas Deferens | Nephritis, Interstitial | Pulmonary Vein Stenosis | Renal Oncocytoma | Scleroderma, Diffuse | Acute Anterior Uveitis | Progressive Familial Intrahepatic Cholestasis | Thyroid Dysgenesis | Muscular Dystrophy | Heimler Syndrome | Eiken Syndrome | Persistent Hyperplastic Primary Vitreous | Hyperkeratosis | Leishmaniasis, Visceral | Pelizaeus-Merzbacher Disease | X-linked Acrogigantism | Transcobalamin Deficiency | Dowling-Degos Disease | Dermatofibrosarcoma | Molybdenum Cofactor Deficiency | Dermatitis Herpetiformis | Addison Disease | Preaxial Polydactyly | Shwachman-Bodian-Diamond Syndrome | Hydrocephalus, Normal Pressure | Amyotrophic Lateral Sclerosis | Bronchiolitis | Kallmann Syndrome | Corneal Ulcer | Aarskog-Scott Syndrome | Familial Hypobetalipoproteinemia | MIRAGE Syndrome | Multiple Epiphyseal Dysplasia | Congenital Dyserythropoietic Anemia Type 1 | Pseudohypoparathyroidism Type 1B | Renal Failure | Glycogen Storage Disease Type 4 | Esophageal Carcinoma | Congenital Bile Acid Synthesis Defect | Pityriasis Rubra Pilaris | Syndactyly | Hyperphosphatasia With Intellectual Disability Syndrome 4 | Urea Cycle Disorder | KBG Syndrome | Aphasia | Conduct Disorder | Familial Retinal Arterial Macroaneurysm | Wilson's Disease | Multiple Sclerosis, Relapsing-remitting | Malignant Peripheral Nerve Sheath Tumor | Inflammatory Myofibroblastic Tumor | Asthma, Exercise-induced | Exocrine Pancreatic Insufficiency | Pneumonia, Bacterial | Trichuriasis | T-cell Chronic Lymphocytic Leukemia | Tularemia | Sensory Ataxic Neuropathy, Dysarthria, And Ophthalmoparesis | Prune Belly Syndrome | Myocardial Infarction | Eczema | Prader-Willi Syndrome | Zollinger-Ellison Syndrome | Sickle Cell Anemia | Waldenstrom Macroglobulinemia | Dyslipidemia | Avian Influenza | Coronary Heart Disease | Hepatic Veno-occlusive Disease | Goldenhar Syndrome | Rhabdoid Tumor | Polycystic Kidney, Autosomal Recessive | Dystrophy, Cone-rod | B-cell Prolymphocytic Leukemia | Spinocerebellar Ataxia Type 5 | Albinism | Perry Syndrome | Choroiditis | Osteonecrosis | Temtamy Preaxial Brachydactyly Syndrome | Seborrheic Dermatitis | Sarcoidosis, Pulmonary | Porphyria Cutanea Tarda | Colitis, Microscopic | Lattice Corneal Dystrophy Type 1 | 6-pyruvoyl-tetrahydropterin Synthase Deficiency | Hepatitis, Chronic | Stroke | Primary Hyperoxaluria Type 1 | Mucolipidosis | Wolfram Syndrome | Hyperostosis | Chondrodysplasia Punctata 2, X-linked Dominant | Transient Bullous Dermolysis Of The Newborn | Ehlers-Danlos Syndrome | Dystonia | Myositis | Sick Sinus Syndrome | Rhizomelic Chondrodysplasia Punctata | Cold-induced Sweating Syndrome | Hypercholesterolemia | Glycogen Storage Disease Type 1 | Asthma, Nocturnal | Congenital Adrenal Hyperplasia 1 | Pulmonary Alveolar Microlithiasis | Bardet-Biedl Syndrome | Leri-Weill Dyschondrosteosis | Thyroid Dyshormonogenesis | Chondrodysplasia Punctata 1, X-linked Recessive | Familial Cerebral Amyloid Angiopathy | Takayasu's Arteritis | Postaxial Polydactyly | Crisponi Syndrome | Spinal And Bulbar Muscular Atrophy | Hypohidrotic Ectodermal Dysplasia, X-linked | Sarcoma | Schwartz-Jampel-Aberfeld Syndrome | Hypoalbuminemia | Guanidinoacetate Methyltransferase Deficiency | Gaucher Disease | Spondylometaphyseal Dysplasia | Sick Sinus Syndrome 1 | Benign Familial Infantile Seizures | Narcolepsy | Autoimmune Autonomic Ganglionopathy | Twin-to-twin Transfusion Syndrome | Spinal Cord Diseases | PASLI Disease | Cystinosis | Keratoconus | Vitamin A Deficiency | Pitt-Hopkins Syndrome | Neuromuscular Disorders | Retinal Telangiectasia | Waardenburg Syndrome Type 4 | Osteoglophonic Dysplasia | Craniofacial Dysostosis | Dystonia Musculorum Deformans | Long QT Syndrome Type 1 | Neurodegeneration Due To Cerebral Folate Transport Deficiency | Dermatomyositis | Epidermolysis Bullosa Simplex, Generalized | Bartter Syndrome | Williams Syndrome | Tic Disorder | Primary Pigmented Nodular Adrenocortical Disease | Arthritis, Gouty | Stargardt Disease | Hereditary Coproporphyria | Pfeiffer Syndrome | Ectopia Lentis, Isolated, Autosomal Recessive | Chromosome 9q34.3 Deletion Syndrome | Hartnup Disease | Asplenia | Sialoadenitis | Autoimmune Polyendocrine Syndrome | Autism | Fanconi Syndrome | Lactose Intolerance | Epidermolytic Hyperkeratosis | Charcot-Marie-Tooth Disease Type 2E | Atherosclerosis | Lipid Storage Diseases | CREST Syndrome | Waardenburg Syndrome Type 2E | Beta-Propeller Protein-associated Neurodegeneration | Combined Malonic And Methylmalonic Acidemia | Micropenis | Bacterial Meningitis | Generalized Epilepsy With Febrile Seizures Plus | Cantu Syndrome | Infantile Nephropathic Cystinosis | Growth Hormone Excess | Sclerosteosis | Pontocerebellar Hypoplasia | Chanarin-Dorfman Syndrome | Myoclonus-dystonia Syndrome | 3-M Syndrome | Lichen Sclerosus | Hereditary Spherocytosis | Giant Axonal Neuropathy | Meckel-Gruber Syndrome | Early Infantile Epileptic Encephalopathy 28 | Rolandic Epilepsy | Hepatorenal Syndrome | Gerstmann-Straussler-Scheinker Syndrome | Pain | Dupuytren Disease | Fascioliasis | Basal Ganglia Cerebrovascular Disease | Cutaneous T-cell Lymphoma | Triple A Syndrome | Syncope | X-linked Charcot-Marie-Tooth Disease | Rett Syndrome | Mucolipidosis Type II | CHARGE Syndrome | Central Pain Syndrome | Brachydactyly | Retinal Dystrophy, Early-onset Severe | Cranioectodermal Dysplasia | Lymphedema-distichiasis Syndrome | Tendinitis | Paroxysmal Nocturnal Hemoglobinuria | Neuromyotonia | Hemochromatosis Type 2 | Epidermolysis Bullosa | Acute Motor Axonal Neuropathy | Birk-Barel Syndrome | Persistent Mullerian Duct Syndrome | Bietti Crystalline Dystrophy | Azoospermia | Myelofibrosis | Alopecia Totalis | Pyruvate Dehydrogenase Deficiency | Retinal Degeneration | Intestinal Hypomagnesemia 1 | Micro Syndrome | Pyruvate Kinase Deficiency | Persistent Truncus Arteriosus | Hypertension, Pulmonary | Neurocutaneous Syndromes | Chiari Malformation Type I | Scabies | Facioscapulohumeral Muscular Dystrophy Type 2 | Behavioral Variant Of Frontotemporal Dementia | Mycosis Fungoides | Carbohydrate Metabolism Disorders | Otosclerosis | Multiple Congenital Anomalies-hypotonia-seizures Syndrome 2 | Supravalvular Aortic Stenosis | Blomstrand Osteochondrodysplasia | Epidermolysis Bullosa Acquisita | Thrombophilia | Anti-NMDA Receptor Encephalitis | Optic Neuropathy, Anterior Ischemic | AIDS | Hepatitis A | Marfan Syndrome | Shock, Cardiogenic | Liddle Syndrome | Blau Syndrome | Membranous Nephropathy | Neurofibromatosis-Noonan Syndrome | Cocaine-Related Disorders | REM Sleep Behavior Disorder | Nail Disorder, Nonsyndromic Congenital | Gastroenteritis | Microcephalic Osteodysplastic Primordial Dwarfism, Type II | Myasthenia | Glycogen Storage Disease Type 6 | Shprintzen-Goldberg Syndrome | Measles | Diastrophic Dysplasia | Agnathia-Otocephaly Complex | Mitochondrial DNA Depletion Syndrome | Chitayat Syndrome | Vitreoretinopathy, Proliferative | Osteogenesis Imperfecta Type II | Sezary Syndrome | Odonto-onycho-dermal Dysplasia